Entering text into the input field will update the search result below
Search for Symbols, analysts, keywords
Forty Seven, Inc.
Stock Price & Overview
FTSV is defunct since March 10, 2019.
See All Analysis »
Gilead completes Forty Seven buy
Gilead nearing finish line on Forty Seven buy
Forty Seven EPS beats by $0.10
Forty Seven teams up with Rocket Pharma in rare pediatric anemia
Gilead takes out Forty Seven for $4.9B
Trillium +44% after report of possible Forty Seven takeover
Gilead Sciences approaches Forty Seven with takeover deal - Bloomberg
Forty Seven (FTSV) Investor Presentation - Slideshow
Key events next week - healthcare
Forty Seven Validates CD47 With 'Don't Eat Me' Tech, Pivotal Studies To Be Initiated In 2020
More News And Analysis »
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.